We are pleased to share that Nicolas Venteclef’s team, Immunity and Metabolism of Diabetes (IMMEDIAB), has been awarded the prestigious FRM team label, a mark of scientific excellence from the Fondation pour la Recherche Médicale, in recognition of the project’s high scientific value and potential impact on metabolic disease research.

This recognition will support their research on the interactions between nutrition, metabolism, and immunity, particularly in the context of type 2 diabetes. Their work explores how specific populations of immune cells, such as monocytes and macrophages, respond to dietary nutrients and contribute to maintaining or disrupting metabolic balance.

By advancing our understanding of nutrient-sensitive immune responses, this project aims to shed new light on the mechanisms that govern diabetes progression and to pave the way for innovative therapeutic strategies.